Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -
Clinical trial NCT02106455 · COMPLETED
Trial details
- NCT number
- NCT02106455
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-08-01
- Primary completion
- 2017-10-24
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.